Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Drug Eluting Stent Registry of Thrombosis (DESERT)
This study is currently recruiting participants.
Verified by Medstar Research Institute, December 2008
Sponsored by: Medstar Research Institute
Information provided by: Medstar Research Institute
ClinicalTrials.gov Identifier: NCT00812552
  Purpose

Multicenter, case-control study, to collect data regarding incidences of late and very late drug-eluting stent thrombosis with the aim of identifying trends and possible correlates of stent thrombosis.


Condition
Coronary Artery Disease

MedlinePlus related topics: Coronary Artery Disease
U.S. FDA Resources
Study Type: Observational
Study Design: Case Control, Retrospective
Official Title: Drug Eluting Stent Registry of Thrombosis

Further study details as provided by Medstar Research Institute:

Primary Outcome Measures:
  • To assess for potential correlates surrounding subjects and lesions among patients that experience late or very late drug-eluting stent thrombosis [ Time Frame: Baseline ] [ Designated as safety issue: No ]

Groups/Cohorts
Case
Late or very late drug-eluting stent thrombosis
Control
No drug-eluting stent thrombosis

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients, male or female, over 18 years of age, who are either known to have experienced late or very late drug-eluting stent thrombosis (Case), or have undergone drug-eluting stent implantation at the same facility, in the same time period as a matched Case Subject, and have not experienced drug-eluting stent thrombosis (Control).

Criteria

Inclusion Criteria:

  • Patients over 18 years of age
  • Case Subjects: patients who have experienced definite late or very late drug-eluting stent thrombosis
  • Control Subjects: patients who underwent drug-eluting stent implantation at the same facility and in the same time period as a matched Case Subject, and have not experienced drug-eluting stent thrombosis.

Exclusion Criteria:

  • Patients not meeting the above Inclusion Criteria
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00812552

Contacts
Contact: Ron Waksman, M.D. 202-877-5975

Locations
United States, District of Columbia
Washington Hospital Center Recruiting
Washington, District of Columbia, United States, 20010
Contact: Ron Waksman, MD     202-877-5975        
Sponsors and Collaborators
Medstar Research Institute
  More Information

Study ID Numbers: DESERT
Study First Received: December 18, 2008
Last Updated: December 18, 2008
ClinicalTrials.gov Identifier: NCT00812552  
Health Authority: United States: Institutional Review Board

Study placed in the following topic categories:
Arterial Occlusive Diseases
Coronary Disease
Embolism and Thrombosis
Heart Diseases
Embolism
Myocardial Ischemia
Vascular Diseases
Arteriosclerosis
Ischemia
Thrombosis
Coronary Artery Disease

Additional relevant MeSH terms:
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 13, 2009